Toll-like receptor 4 (TLR-4) is required for detection of Gram negative bacterial infections by binding lipopolysaccharide (LPS) and for the initiation of inflammatory signaling. Recent studies have demonstrated that a nonsynonymous single-nucleotide polymorphism (Asp299Gly, A þ 896G) is associated with decreased endotoxin responsiveness and poor outcomes from sepsis. We show that human carriers of this polymorphism show no deficit in LPS induced peripheral blood mononuclear cell (PBMC) mitogen-activated protein kinase (MAPK) activity, no reduction in sensitivity to endotoxin, and variable differences in whole-blood inflammatory cytokine production. These results indicate that this mutation is not a primary determinant of human endotoxin sensitivity.
Introduction
Genetic variation in the innate immune response likely contributes to the marked variation seen in the risk for and outcome from infectious diseases, including sepsis. Epidemiologic studies have demonstrated a strong familial association with death from infectious disease in general and, more specifically, an association between a familial 'anti-inflammatory' response and death from meningococcal sepsis. 1, 2 The role of specific genetic differences in conferring risk is less certain, with many examples of discordant observations regarding numerous genetic variants. Examples of conflicting observations have primarily concerned single-nucleotide polymorphisms (SNPs) in genes involved in the innate immune response, such as tumor necrosis factor-alpha (TNF-a), lipopolysaccharide (LPS) binding protein (LBP) and CD14. [3] [4] [5] [6] LPS is a major component of the outer wall of Gram negative bacteria, serving as the key ligand for immune cell recognition and activation in response to infection. Innate immune cells, such as macrophages and monocytes, recognize endotoxin by a specific receptor complex, which contains CD14, LPS, LBP, and Toll-like receptor-4 (TLR4). Recognition by this receptor complex leads to the activation of specific mitogen-activated kinases (MAPK), including p38, and the synthesis and release of pro-inflammatory cytokines, including TNF-a, interleukin-1b (IL-1b), and IL-6.
7 TLR4 is central to LPS signaling. Its role is highlighted by animal and in vitro studies that have identified mutations in the TLR4 gene associated with hypo-responsiveness to LPS and hypersusceptibility to infection by Gram negative bacteria. [8] [9] [10] [11] Polymorphisms within the TLR4 gene may influence inflammatory responses in important ways. In particular, a biallelic SNP in the human TLR4 gene has been identified with a frequency approaching 10% in Caucasian populations 12 located in exon three at position þ 896 base pairs (bp) from the transcriptional start site. This polymorphism represents an A-G base transition resulting in an aspartic acid to glycine exchange at position 299 in the amino-acid sequence (referred to as Asp299Gly or A þ 896G) and often cosegregates with another mutation at þ 1196. This second SNP is a nonsynonymous C-T transition, replacing threonine with isoleucine at position 399 (referred to as Thr399Ile or C þ 11996T). The TLR4 þ 896 variant (G allele) confers an alteration to the extracellular domain of the TLR4 receptor. Carriers have been reported to have an impaired response to bacterial endotoxin exposure compared to wild-type controls, [13] [14] [15] [16] and they may be at increased risk for Gram negative infections and septic shock, and mortality from systemic inflammatory response syndrome (SIRS). [17] [18] [19] However, other in vivo and clinical studies have shown inconsistencies in the link between coding SNPs in the TLR4 gene and the inflammatory response. [20] [21] [22] We sought to determine the effect of the A þ 896G polymorphism within the TLR4 gene on the response to LPS in a population of healthy donors. We assessed the variability of wild type and carriers with respect to LPS induced ex vivo PBMC activity of MAPK p38. Next, we analyzed the effect that the variant allele may have on LPS induced whole-blood production of the inflammatory cytokines, TNFa, IL-1b, and IL-6. In order to control for influences that polymorphisms within the cytokine genes may have on cytokine production, we screened for three candidate polymorphisms (annotated by nucleotide transition and gene position relative to the transcription start site): TNF-a (G-308A), IL-1b (C-31T), and IL-6 (G-174C). Our overall hypothesis was that a single SNP, although leading to a change in the protein sequence, would have minimal influence of measures of endotoxin responsiveness.
Results
The A þ 896G SNP does not influence whole blood leukocyte sensitivity to endotoxin Venous whole-blood samples were drawn on three occasions from 12 healthy subjects (eight wild type and four G-allele carriers). For each subject, a dose-response curve was generated, plotting supernatant cytokine concentration against LPS concentration ( Figure 1a ). The LPS concentration that resulted in a half-maximal response (EC 50 ) was calculated as an estimate of leukocyte sensitivity to LPS and compared between þ 896 genotypes. There was no difference in log EC 50 for IL-6 production when comparing carriers of the TLR4 þ 896G allele and wild-type allele controls (Figure 1b) . We also observed no difference in the log EC 50 in TNF-a and IL-1b production in these same experiments ( Figure  1c and d).
p38 mitogen activated protein kinase activity is not influenced by the A þ 896G SNP In order to evaluate the TLR4 signal transduction pathway proximal to cytokine production, we measured the activity of MAP kinase p38 after exposure of PBMCs from 12 additional control subjects (eight wild type and four þ 896G allele carriers). PBMC p38 activity was unaffected by TLR4 polymorphism carrier status in these subjects ( Figure 2 ).
The A þ 896G SNP is not a primary determinant of whole-blood inflammatory cytokine responses Our initial dose-response and p38 activation experiments involved relatively few subjects and may have been underpowered to detect small differences in endotoxin responsiveness. We therefore conducted additional experiments using a single endotoxin (a) Sample plot with superimposed nonlinear best fit line of whole-blood IL-6 production vs log of LPS dose (g/ml) from one subject (results are a combination of three experiments carried out in six replicates). Dotted line represents the EC 50 (concentration of LPS required to elicit a half-maximal response) of LPS 10 À8.25 g/ml. A similar dose-response relationship and EC50 was generated for a group of wild-type subjects and þ 896G variants (each subject underwent three experiments carried out in six replicates). Dot plots are shown of log EC 50 of LPS comparing wild type (WT) to TLR4 ( þ 896G) variants for (b) IL-6 (log EC 50 , mean7s.e.m., wild type À8.6970.24 vs variant þ 896 G allele À8.5270.28, P ¼ 0.69) (c) IL-1b (log EC50, mean7s.e.m., wild type À6.5270.55 vs variant þ 896 G allele À7.0670.63, P ¼ 0.67), and (d) TNF-a (log EC 50 , mean7s.e.m., wild type À8.2570.41 vs variant þ 896 G allele À7.4270.81, P ¼ 0.67). Horizontal lines represent the mean for each group. concentration in 80 healthy subjects: 72 were homozygous wild type for the A þ 986G, and eight were carriers of the G-allele ( Figure 3 ). In these experiments, we exposed whole-blood leukocytes to an endotoxin concentration reflecting the steepest portion of the doseresponse curve (1 Â 10 À8 g/ml) as differences in LPS responsiveness would be most likely demonstrable. Although G-allele carriers released less IL-1b in response to LPS (Figure 3a ), there were no differences in supernatant concentrations of TNF-a (Figure 3b ) or IL-6 ( Figure 3c ). After adjusting for sex, the difference in IL1b cytokine production based on TLR4 A þ 896G status was no longer significant (P ¼ 0.177 by ANOVA).
In order to adjust for potential effect of other polymorphisms that have been observed to influence specific cytokine gene activity and protein production, we also genotyped our subjects for SNPs in the IL-1b (T-31C), IL-6 (G-174C) and TNF-a (G-308A) promoters. Adjusting for these SNPs in our analyses did not influence our observations regarding cytokine production and the TLR4 A þ 896G SNP.
As this cohort of 80 subjects was multiethnic, we conducted a second analysis, limited to the 70 Caucasian subjects, and our observations did not change from that which we saw in the entire cohort (data not shown).
Discussion
The frequencies of the TLR4 A þ 896G polymorphism in our study sample was similar to previously published series (5-10%). [13] [14] [15] Although several groups have shown a correlation between carrier status for the coding polymorphisms in TLR4 and alterations in LPS signaling, [13] [14] [15] other investigators have not. 20, 22 Our observations suggest that any effect of the variant allele is minimal as we did not observe differences in MAPK IL-6 (pg/ml) c Figure 3 Whole-blood LPS induced proinflammatory cytokine production does not differ based on donor TLR4 genotype. Dots plots represent whole-blood cytokine production in subjects homozygous wild type (n ¼ 72, WT) or heterozygous variant activation and saw no differences in sensitivity, based upon the EC50, to endotoxin. We only observed differences in one of three cytokines (IL-1b) assayed between TLR4 þ 896 wild type and variant allele carriers in a larger cohort of subjects. The lower IL-1b production that we observed by whole-blood leukocytes from the TLR4 þ 896 G-allele carriers was in part due to an imbalance in gender between the two groups. A greater proportion of G-allele carriers were females, in whom we observed somewhat lower IL-1b and TNF-a production than the male subjects. After adjusting for the sex of the subjects in our analyses of cytokine production, gender was relatively more important than carriage of the TLR4 þ 896 G-allele.
Our observations add to the body of literature regarding the potential role of this TLR4 polymorphism in endotoxin responsiveness in a number of ways. 20, 22 First, we have demonstrated a similar degree of activation of intracellular signaling, based upon p38 MAPK phosphorylation. Second, we incorporated an estimate of sensitivity to endotoxin by determining a dose-response to endotoxin. 20 Third, based upon this curve, we selected an endotoxin concentration located on the steepest part of this curve-a point where differences in endotoxin responses would most likely be demonstrable. Finally, we adjusted for additional polymorphisms in the genes of the cytokines we measured. Taken together, our data are most consistent with the hypothesis that the A þ 896G SNP alone is not a major determinant of endotoxin responsiveness.
Evidence favoring the importance of TLR4 polymorphisms in endotoxin responsiveness emerges from data in human and non-human models. Mutations in TLR4 gene have been identified in mouse strains defective in their response to LPS, and disruption of TLR4 results in an LPS hyporesponsive phenotype.
9,10 A study by Arbour et al 13 in a human model of inhaled endotoxin demonstrated that carriers of the þ 896G/ þ 1196T variant demonstrated a decreased responsiveness. Supportive in vitro studies demonstrated a decrease in TLR4 protein expression, NFkB activity, and LPS induced IL-1a production in variant carriers. These observations have been repeated by others. 14, 15 There is less compelling evidence regarding the role of these TLR4 variants in the clinical setting of sepsis and shock. Two groups have observed associations among the TLR4 þ 896G/ þ 1196T variant and the incidence of Gram negative infections and septic shock in ICU patients. 17, 18 These clinical studies suffer from small sample size and the absence of correlating biologic data such as in vivo cytokine or cell signaling. Furthermore, other clinical and basic science investigations have failed to demonstrate a role for TLR4 in altering the inflammatory response. [19] [20] [21] [22] [23] [24] [25] There are several possibilities that may explain the lack of association between TLR4 genotype and measures of endotoxin signaling we have observed. [26] [27] [28] First, as there were no individuals homozygous for the TLR4 þ 896G allele, the remaining wild-type TLR4 allele in heterozygous carriers may be sufficient to elicit a normal response to endotoxin. 29 It is possible that homozygosity for the variant allele (a relatively rare occurrence) would be necessary to confer differences in the responses we tested. The lack of such homozygous individuals in our sample does not allow us to address this hypothesis. Interestingly, reports that have demonstrated an association between endotoxin hypo-responsiveness and carriage of the TLR4 þ 896G allele have examined airway reactivity or systemic cytokine responses to inhaled endotoxin. [13] [14] [15] Studies that have not demonstrated an association were focused primarily on endotoxin responses in circulating leukocytes, 20, 22, 24, 25 which mimics endotoxemia and clinical sepsis. 19, 21 Numerous factors, including LBP, CD14 and serum HDL, among other molecules modulate LPS recognition and binding to TLR4, and interindividual differences in their effects may have important influences on leukocyte responses to endotoxin measured in our studies and seen clinically.
An intriguing alternative hypothesis posits that relatively common coding polymorphisms, such as the TLR4 þ 896G and þ 1196T variants, do not confer susceptibility to infection, but rather that an excess of more rare coding polymorphisms are responsible for observed differences. Work by Smirnova et al 30 demonstrated a predominance of rare coding polymorphisms in a population of 197 patients with meningococcal disease; whereas, the þ 896G/ þ 1196T variant existed in nearly equal frequency among the affected and healthy groups. A multiple-loci genetic load model, in which one or more functional polymorphisms in one or more genes of the endotoxin response pathway may be responsible for differing phenotypic responses. 16, 30 This hypothesis may explain why studying a single or at most a few polymorphisms located in one gene has yielded results that are difficult to reproduce. Studying rare polymorphisms in multiple genes in the innate immune pathways may provide a more comprehensive picture of the heritability of infection, infection severity, and death. 1 Despite being a commonly used technique, limitations in using LPS stimulation of whole-blood exist. 31 Despite the ease of assaying whole blood and the minimal amount of tissue perturbation required compared with monocyte isolation, it is difficult to correct for differences in leukocyte count among individuals as well as the influence of various soluble factors, such as LBP and soluble CD14, which may modify endotoxin signaling. Our previous study, in which we adjusted for blood monocyte counts, provides reassurance that any differences in circulating monocyte numbers have little effect on our observations. 32 In addition, our whole-blood samples were diluted 10-fold to minimize the effect that soluble factors in the donor plasma may have on LPS response. In addition, we isolated PBMCs from wholeblood samples to assess MAPK activity. This technique eliminates many of the limitations of whole-blood assays, though carries the possibility that the extra manipulation involved in their isolation may alter subsequent responsiveness.
Our analysis was unable to detect differences in MAPK activation among individuals wild type for the A þ 896G polymorphism compared with variant carriers. Phosphorylated p38 was detected and quantified using Western blot analysis and densitometry. This technique may lack sufficient sensitivity to distinguish subtle differences in protein phosphorylation between genotypes. However, because the results of these p38 activation experiments were consistent with the cytokine results reported here, it is reasonable to consider the measurement of p38 activation as sufficiently sensitive to detect important differences. Furthermore, we also assayed p38 activation using a commercially available ELISA (Biosource International, Camarillo, CA, USA) and observed findings nearly identical to those from the densitometry results.
This analysis highlights emerging evidence that SNPs in other pathway genes need to be examined. Even the LPS recognition complex and signal transduction pathway involves many candidate genes, in which various polymorphisms may alter phenotype. These include candidate polymorphisms in genes for bactericidal/ permeability increasing protein, LBP, 6,33 CD14, 34-36 MD-2, 37 Myeloid Differentiation Factor 88 (MyD88), 38, 39 and IL-1 receptor-associated kinase (IRAK). 40, 41 As other have stated, the genetic determinants responsible for the host response to injury or infection are largely polygenic or weakly penetrant. 42 These observations may explain why candidate gene studies involving single polymorphisms are difficult to replicate. It is more plausible to conclude that genetic contributions to an impaired immune response or sepsis susceptibility may involve one or several mutations present in known and, as yet unknown, candidate genes involved in the innate immune response. Our study provides more evidence that the TLR4 A þ 896G polymorphism in isolation, and when carried in the heterozygous state, may not alter LPS signaling in innate immune cells.
Materials and methods
All studies were approved by the University of Washington Institutional Review Board, and all subjects provided written informed consent.
Detection of gene polymorphisms
In total, 80 healthy subjects were screened for the presence of the TLR4 mutations Asp299Gly (A þ 896G) and Thr399Ile (C þ 1196T), as well as, TNF (G-308A), IL-1b (C-31T), and IL-6 (G-174C). The SNP genotyping assays were designed by Applied Biosystems, Foster City, CA, USA. The assays use specific reporter dyelabeled Taqman Table 1 . Assays were conducted in 384-well format on an ABI PRISM s 7900 HT Sequence Detection System (Applied Biosystems). Reaction conditions were the following: initial denaturation at 951C for 10 min, followed by 40 cycles each of denaturation (951C for 15 s) and annealing/extension (601C for 60 s).
Cell isolation and treatment
Venous EDTA-anticoagulated blood samples were drawn from healthy volunteers. Whole-blood aliquots were diluted 1 : 10 in RPMI 1640 (Biowhittaker, Walkersville, MD, USA) and incubated 12-well tissue culture plates at 371C/5% CO 2 . Cells were exposed to Escherichia coli K12-LCD25 LPS (List Biological Laboratory, Inc. Campbell, CA, US A) at a dose of 1 Â 10 À8 g/ml (10 ng/ml) for 4 h prior to harvesting of cell-free supernatant. Concentrations of supernatant TNF-a, IL-1b, and IL-6 were Cell lysis and Western blot analysis Total cellular protein was extracted at 41C in 1 ml of lysis buffer (20 mM Tris, 137 mM NaCl, 2 mM EDTA, 10% glycerol, 1% Triton X-100, 1 mM sodium orthovanadate, 100 mM DTT, 200 mM PMSF, 10 mg/ml leupeptin, 2.5 mg/ml pepstatin A, 1 mM benzamidine, 10 mM b-glycerophosphate, 0.15 U/ml aprotinin, 50 mM sodium fluoride, 10 mM sodium pyrophosphate). Protein concentration was determined using BCA protein assay (Pierce, Rockford, IL, USA). Total cell lysates were separated by electrophoresis on a 10% SDS-PAGE gel and transferred onto a Hybond-ECL nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ, USA). The membrane was blocked for 1 h at room temperature with 5% milk and incubated in 5% BSA with an antidual phosphorylated p38 antibody (Cell Signaling Technologies, Beverly, MA, USA) for 12 h at 41C. Blots were developed using SuperSignal chemiluminescent substrate (Pierce, Rockford, IL, USA) and exposed on Kodak KAR-5 film. Densitometry was performed by the NIH image program to quantitate optical density. All gels were re-blotted for total p38 to confirm equal protein loading.
Statistical analysis
Statistical analysis was performed with Prism GraphPad (Version 4.0, 2003, San Diego, CA, USA) and SPSS (Version 11.0, 2003, Chicago, IL, USA). Data are presented as median and interquartile range or as mean þ standard error of the mean (s.e.m.) where appropriate. p38 data were analyzed with repeated measures analysis of variance (ANOVA). The cytokine data followed a nonparametric distribution and were thus analyzed with the Mann-Whitney U test. In the case of cytokine data, we used ANOVA to analyze the effects of multiple polymorphisms on individual cytokine concentrations. Both the actual data and a logarithmic transformation of the data were used in the ANOVA models and as the results were almost identical, the results of the analyses of the untransformed data are presented. In all cases, actual P-values are reported.
